Evaxion AS (EVAX)
2.83
+0.03
(+1.07%)
USD |
NASDAQ |
Oct 16, 16:00
3.25
+0.42
(+14.84%)
After-Hours: 20:00
Evaxion Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0008M |
| September 30, 2023 | -0.0649M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -0.1586M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.1792M |
| September 30, 2021 | -0.3283M |
| June 30, 2021 | -0.4942M |
| March 31, 2021 | -0.3262M |
| December 31, 2020 | -0.2827M |
| September 30, 2020 | 0.0135M |
| June 30, 2020 | -0.0455M |
| March 31, 2020 | -0.081M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 68.03M |
| DBV Technologies SA | -0.5998M |
| Cellectis SA | 18.75M |
| Akari Therapeutics Plc | 0.00 |
| Bicycle Therapeutics Plc | -0.266M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -129.8% |